Bufler Michael HSLU T&A

Prof. Dr. Michael Bufler Michael Bufler

Professor

Bufler Michael HSLU T&A

Lucerne School of Engineering and Architecture

Room 134
Technikumstrasse 21
6048 Horw


Institute of Medical Engineering IMT

CC Bioscience and Medical Engineering

Professor

+41 41 349 35 96

Show email

Biography

  • Since 2024 Hochschule Luzern (HSLU): 
    Professor and Lecturer for Medical Engineering & Life Science
  • 2021-2024: Director of Research, Geistlich Pharma AG
  • 2013-2021: Director of Material Research & Technologies, Geistlich Pharma AG
  • 2008-2012: Associate Director of Core Technologies, Geistlich Pharma AG
  • 2004-2008: Head of Analytical Research, Geistlich Pharma AG

 

Education

  • Dipl. Min., 
    Johannes-Gutenberg University Mainz, Germany
  • Dr. rer. nat. Chemistry, 
    University of Siegen, Germany. 
    Thesis: «Calciumphosphate - Synthese, Reaktionen in wässrigen Medien und Charakterisierung von Oberflächen und Grenzflächen» 

 

Further Training

Gerätequalifizierung und -Überwachung im Analytik Labor, GMP-/FDA Compliance in der Qualitätskontrolle, Risikoanalyse und Risikomanagement für Medizinprodukte, Particles and Thin Films,  Microencapsulation and Particle Coating, Röntgenbeugung und Rietveldanalyse, Preparing for & Surviving an FDA Inspection, CAPA Course, Erfolgreiches Projektmanagement in der Praxis, Agiles Projektmanagement (Scrummaster, Product Owner).

Subjects
  • (1) Grundlagen Physikalische & Analytische Chemie
  • (2) Einführung Laboranalytik
  • (3) Konstruktion und Festigkeit von Medizinprodukten
  • (4) Labor- und Personalmanagement
  • (5) Biologische Sicherheit von Medizinprodukten
Professional competencies
  • - Medical Engineering, Medical Devices, Pharma
  • - KMU/SME Requirements, Stakeholder Management
  • - Research & Product Development from idea to product registration and beyond
  • - Evaluation and Implementation of Customer Needs, Market Requirements and Trends
  • - Product Strategy & Innovation Management
  • - Patenting of ideas (IP) - 165 Patents
  • - Budget Management, financial midterm- and strategic longterm planning
  • International and Interdisciplinary Project Management
  • - Organizational Change Management
  • - Validation, Qualification, GMP
Teaching and research focus
  • - Materials in Medical Engineering & Life Science
  • - Surface- and interface science of biomaterials and medical devices
  • - Structure-property relationships and interaction principles
  • - Biomaterials for bone and soft tissue regeneration
  • - Analytical testing and Material Characterization in Medical Engineering & Life Science
  • - Lab-based diagnostics
  • - Laboratory management (GMP / non-GMP)
  • - Biological safety of materials

Biomedical Materials Science, Medical Devices, Biomaterials, Tissue Regeneration, Bioactive Materials

Publications and presentations

Publications and presentations - Theses (Bachelor/Master/Dissertation/Habilitation)

  • Bufler, Michael (2004). Calciumphosphate : Synthese, Reaktionen in wässrigen Medien und Charakterisierung von Oberflächen und Grenzflächen. Dissertation, Universität Siegen, Deutschland.

Achievements

    • Bufler, Michael (27.01.2022). Method for treating subjects suffering from chronic ulcers No. 20220023498. All Europen countries covered by the EPO, USA, Japan, China, Australia: USPO.

    • Bufler, Michael (12.05.2021). Biomimetic collagen-hydroxyapatite composite material No. AU2018201667B2. Australia: IP Australia.

    • Bufler, Michael (15.04.2021). Biomimetic collagen-hydroxyapatite composite material No. JP2021052620A. Japan: Japan Patent Office.

    • Bufler, Michael (31.03.2021). Biphasic calcium phosphate/hydroxyapatite (CAP/HAP) bone substitute material No. AU2019298596B2. Australia: IP Australia.

    • Bufler, Michael (30.03.2021). Collagen matrix or granulate blend of bone substitute material No. 10960107. Unites States: USPTO.

    • Bufler, Michael (24.11.2020). Biphasic calcium phosphate/hydroxyapatite (CAP/HAP) bone substitute material No. BR112020013781-5. Brazil: Brazilian National Institute of Industrial Property.

    • Bufler, Michael (05.09.2020). Biomimetic collagen-hydroxyapatite composite material No. CN106850872B. China: China National Intellectual Property Administration.

    • Bufler, Michael (21.07.2020). Biomimetic collagen-hydroxyapatite composite material No. BR112018015688-0. Brazil: Brazilian National Institute of Industrial Property.

    • Bufler, Michael (28.05.2020). Biphasic calcium phosphate/hydroxyapatite (CAP/HAP) bone substitute material No. JP2020080703A. Japan: Japan Patent Office.

    • Bufler, Michael (12.05.2020). Bone Substitute Material No. 10646615. United States: USPTO.

    • Bufler, Michael (04.02.2020). Biphasic calcium phosphate/hydroxyapatite (CAP/HAP) bone substitute material No. KR20200011012A. Korea: Korean Intellectual Property Office.

    • Bufler, Michael (17.10.2019). Biomimetic collagen-hydroxyapatite composite material No. KR1020190080076A. Korea: Korean Intellectual Property Office.

    • Bufler, Michael (25.09.2019). Bone Substitute Material No. 20200016293. United States: USPTO.

    • Bufler, Michael (11.07.2019). Bone Substitute Material No. 20190209737. United States: USPTO.

    • Bufler, Michael (09.07.2019). Hydrophilic phosphate group containing dehydrated partially purified bone replacement material No. BR112015002121-2. Brazil: Brazilian National Institute of Industrial Property.

    • Bufler, Michael (03.10.2018). Biphasic calcium phosphate/hydroxyapatite (CAP/HAP) bone substitute material No. CN106630181B. China: China National Intellectual Property Administration.

    • Bufler, Michael (07.03.2018). Collagen Matrix or Granulate Blend of Bone Substitute Material No. EP3108997A1. Valid in all EPO member states: European Patent Office (EPO).

    • Bufler, Michael (22.03.2017). Biphasic calcium phosphate/hydroxyapatite (CAP/HAP) bone substitute material No. EP2796634B1. Valid in all EPO member states: European Patent Office (EPO).

    • Bufler, Michael (15.03.2017). Hydrophilic phosphate group containing dehydrated partially purified bone replacement material No. ZL201380040358.0. China: China National Intellectual Property Administration.

    • Bufler, Michael (14.12.2016). Biomimetic Collagen-Hydroxyapatite Composite Material No. EP2922651B1. Valid in all EPO member states: European Patent Office (EPO).

    • Bufler, Michael (29.04.2016). Hydrophilic phosphate group containing dehydrated partially purified bone replacement material No. 10-1619033. Korea: Korean Intellectual Property Office.

    • Bufler, Michael (21.10.2015). Hydrophilic phosphate group containing dehydrated partially purified bone replacement material No. 2879726. All countries covered by the EPO: EPO.

    • Bufler, Michael (30.06.2015). Bone Substitute Material No. 9066995. United States: United States Patent and Trademark Office (USPTO).

Achievements - Patent

  • Bufler, Michael (27.01.2022). Method for treating subjects suffering from chronic ulcers No. 20220023498. All Europen countries covered by the EPO, USA, Japan, China, Australia: USPO.
  • Bufler, Michael (12.05.2021). Biomimetic collagen-hydroxyapatite composite material No. AU2018201667B2. Australia: IP Australia.
  • Bufler, Michael (15.04.2021). Biomimetic collagen-hydroxyapatite composite material No. JP2021052620A. Japan: Japan Patent Office.
  • Bufler, Michael (31.03.2021). Biphasic calcium phosphate/hydroxyapatite (CAP/HAP) bone substitute material No. AU2019298596B2. Australia: IP Australia.
  • Bufler, Michael (30.03.2021). Collagen matrix or granulate blend of bone substitute material No. 10960107. Unites States: USPTO.
  • Bufler, Michael (24.11.2020). Biphasic calcium phosphate/hydroxyapatite (CAP/HAP) bone substitute material No. BR112020013781-5. Brazil: Brazilian National Institute of Industrial Property.
  • Bufler, Michael (05.09.2020). Biomimetic collagen-hydroxyapatite composite material No. CN106850872B. China: China National Intellectual Property Administration.
  • Bufler, Michael (21.07.2020). Biomimetic collagen-hydroxyapatite composite material No. BR112018015688-0. Brazil: Brazilian National Institute of Industrial Property.
  • Bufler, Michael (28.05.2020). Biphasic calcium phosphate/hydroxyapatite (CAP/HAP) bone substitute material No. JP2020080703A. Japan: Japan Patent Office.
  • Bufler, Michael (12.05.2020). Bone Substitute Material No. 10646615. United States: USPTO.
  • Bufler, Michael (04.02.2020). Biphasic calcium phosphate/hydroxyapatite (CAP/HAP) bone substitute material No. KR20200011012A. Korea: Korean Intellectual Property Office.
  • Bufler, Michael (17.10.2019). Biomimetic collagen-hydroxyapatite composite material No. KR1020190080076A. Korea: Korean Intellectual Property Office.
  • Bufler, Michael (25.09.2019). Bone Substitute Material No. 20200016293. United States: USPTO.
  • Bufler, Michael (11.07.2019). Bone Substitute Material No. 20190209737. United States: USPTO.
  • Bufler, Michael (09.07.2019). Hydrophilic phosphate group containing dehydrated partially purified bone replacement material No. BR112015002121-2. Brazil: Brazilian National Institute of Industrial Property.
  • Bufler, Michael (03.10.2018). Biphasic calcium phosphate/hydroxyapatite (CAP/HAP) bone substitute material No. CN106630181B. China: China National Intellectual Property Administration.
  • Bufler, Michael (07.03.2018). Collagen Matrix or Granulate Blend of Bone Substitute Material No. EP3108997A1. Valid in all EPO member states: European Patent Office (EPO).
  • Bufler, Michael (22.03.2017). Biphasic calcium phosphate/hydroxyapatite (CAP/HAP) bone substitute material No. EP2796634B1. Valid in all EPO member states: European Patent Office (EPO).
  • Bufler, Michael (15.03.2017). Hydrophilic phosphate group containing dehydrated partially purified bone replacement material No. ZL201380040358.0. China: China National Intellectual Property Administration.
  • Bufler, Michael (14.12.2016). Biomimetic Collagen-Hydroxyapatite Composite Material No. EP2922651B1. Valid in all EPO member states: European Patent Office (EPO).
  • Bufler, Michael (29.04.2016). Hydrophilic phosphate group containing dehydrated partially purified bone replacement material No. 10-1619033. Korea: Korean Intellectual Property Office.
  • Bufler, Michael (21.10.2015). Hydrophilic phosphate group containing dehydrated partially purified bone replacement material No. 2879726. All countries covered by the EPO: EPO.
  • Bufler, Michael (30.06.2015). Bone Substitute Material No. 9066995. United States: United States Patent and Trademark Office (USPTO).